We’ve recently received a number of inquiries about the use of GLP-1 receptor agonists, and are therefore pleased to share that the first clinical trial to investigate their potential use in the treatment of lymphedema is now enrolling patients!
Additional details can be read in this Press Release. For more information about the study or to inquire about participation, please email lymphstudy@arsahealth.com or contact Giana Truax at 866-266-2577 ext. 1860.
With regard to potential future insurance coverage, before any advocacy for that could occur, it must first be proven as a safe and effective treatment for lymphedema, so this study is an important step in that direction.
We do not have any other information beyond what is provided here, so please use the email address or phone number above to direct any questions to the study organizers.
Heather Ferguson
Founder & Executive Director
Lymphedema Advocacy Group
LymphedemaAdvocacyGroup.org
